Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
26.32
+0.06 (+0.23%)
Official Closing Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
February 21, 2024
Moderna reports Q4 earnings on Feb. 22. Analysts expect $2.53B in revenue. Stock has faced challenges but potential for recovery with COVID-19 vaccine and FDA approval in 2024.
Via
Benzinga
Exposures
COVID-19
Product Safety
Pfizer Unusual Options Activity For February 21
February 21, 2024
Via
Benzinga
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?
February 21, 2024
Relying on payout ratio alone can sometimes give investors a misleading picture of just how safe a dividend payment is.
Via
The Motley Fool
3 Cheap Dividend Stocks to Snatch Up Now
February 20, 2024
Cheap dividend stocks offer rebound upside paired with an income source that is difficult to beat for most investors.
Via
InvestorPlace
Get Rich Quick with These 7 Growth Stocks to Buy Now
February 20, 2024
Here are seven growth stocks to buy that will let you know by their price action if the current bull market is ready to expand.
Via
InvestorPlace
Exploring NYSE:PFE's dividend characteristics.
February 20, 2024
Exploring PFIZER INC (NYSE:PFE)'s dividend characteristics.
Via
Chartmill
Behind the Scenes of Pfizer's Latest Options Trends
February 13, 2024
Via
Benzinga
Wall Street Favorites: 7 Long-Term Stocks With Strong Buy Ratings for February 2024
February 20, 2024
The stock market is soaring, and many analysts are worried about a bubble. Still, these seven long-term stocks are still great buys today.
Via
InvestorPlace
2 Ultra-High-Yield Dividend Stocks Billionaires Can't Stop Buying, and 1 They Can't Sell Fast Enough
February 20, 2024
Two brand-name income stocks with yields north of 6% were gobbled up by prominent billionaires in the December-ended quarter, while a dividend stock with a 15% yield found itself on the chopping...
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Via
Benzinga
7 Blue-Chip Stocks to Pick Up While They’re Down
February 18, 2024
Build a robust investment portfolio and make the most of the discount with these blue-chip stocks to buy and hold.
Via
InvestorPlace
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 17, 2024
Patience will be rewarded with these stocks.
Via
The Motley Fool
Pfizer's Expansion Sparks Boom for these Healthcare REITs
February 16, 2024
Via
Benzinga
7 F-Rated Stocks to Sell for February 2024
February 16, 2024
The stock market is off to a good start and there are plenty of great names out there. So don't hold on to your F-rated stocks to sell.
Via
InvestorPlace
Pfizer's Mixed Bag: A Look At The Fourth Quarter 2023 Earnings Call - Main Takeaways
February 15, 2024
Pfizer Inc. (NYSE: PFE) recently held its fourth-quarter earnings call, revealing a year of contrasts for the pharmaceutical giant. While the company faced setbacks, particularly with its COVID-19...
Via
Benzinga
Topics
Earnings
Exposures
COVID-19
Financial
The 3 Biotech Stocks That Could Make Your February Unforgettable
February 15, 2024
After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.
Via
InvestorPlace
The 7 Best Dividend Stocks to Buy in February 2024
February 15, 2024
The market is soaring and many sectors appear overvalued. Fortunately, these leading dividend stocks are still available at great prices.
Via
InvestorPlace
7 Undervalued Dividend Stocks to Buy in February for High Total Returns
February 15, 2024
The undervalued dividend stocks could see serious growth before too long. Plus, they pay you to hold them while you wait.
Via
InvestorPlace
Pfizer Agrees To Pay $93M To Settle Lipitor Antitrust Lawsuit Despite Calling Allegations 'Factually And Legally Without Merit'
February 15, 2024
Pfizer has agreed to pay $93 million to settle an antitrust lawsuit related to its cholesterol drug Lipitor.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Biden Boom: 7 Stocks to Buy if Democrats Win the Election in 2024
February 14, 2024
Election-proof your portfolio: these seven stocks could deliver significant gains if Biden wins the election in 2024.
Via
InvestorPlace
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
February 14, 2024
Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.
Via
InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
February 14, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
7 High-Yield Dividend Stocks for the Ultimate Retirement Portfolio
February 13, 2024
Discover seven high-yield dividend stocks for retirement across diverse sectors, including telecommunications, REITs, and pharmaceuticals.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
3 Blue-Chip Stocks Drowning in Earnings Despair
February 13, 2024
Investors should shy away from these companies after they delivered substandard financial results for the final months of last year.
Via
InvestorPlace
The 3 Best Biotech Stocks to Buy in February 2024
February 13, 2024
The best biotech stocks to buy offer consistent growth opportunities and resist the influence of singular drug successes.
Via
InvestorPlace
Contrarian Plays: 3 Stocks Going Against the Grain That Could Deliver Huge Gains
February 13, 2024
The conventional wisdom is that these stocks are going nowhere. But the conventional wisdom just might be wrong.
Via
The Motley Fool
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
The 7 Best Momentum Stocks You Can Purchase Today
February 12, 2024
If you’re looking for hot opportunities in the market, here are just a few of the best momentum stocks to buy today.
Via
InvestorPlace
Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
February 12, 2024
Insights from Wedbush analysts about the clinical effectiveness of REGENXBIO's RGX-202, market potential, and challenges posed by competitors like Sarepta Therapeutics and Pfizer.
Via
Benzinga
Super Bowl Commercials 2024: Complete List Of Super Bowl LVIII Ads And Companies Behind Them
February 12, 2024
The complete list of Super Bowl LVIII commercials and the companies behind them, including the stock tickers.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.